FDA Investigator Leslie Arivera Rosado, PhD

Leslie Arivera Rosado, PhD has conducted inspections on 3 sites in 3 countries as of 25 Feb 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
3
Last Inspection Date:
25 Feb 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
100006864
Countries of Inspections:
Japan, India, United States of America
FDA Investigators that have inspected at least one site in common with Leslie Arivera Rosado, PhD:
Aditi S Thakur, Amy Devlin, PhD, Angela E Glenn, Arsen Karapetyan, Ashutosh Rao, PhD, Bijoy Panicker, Bo Chi, PhD, Bonita S Chester, Charles Yuanchia Kuo, PhD, Christopher Downey, PhD, Daniel J Roberts, Devaughn Edwards, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Hyung Yul Lee, Jacek Cieslak, PhD, Jason F Chancey, Jeanne Fringer, PhD, Jee Chung, PhD, Lakshmi Narasimhan, PhD, Leopold Kong, PhD, Mary Kaulee, Massod Rahimi, PhD, Maxwell Van Tassell, PhD, Michael Shanks, MS, Nina Brahme, PhD, MPH, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paula A Trost, Penny H Mccarver, Reyes Candau Chacon, PhD, Santos E Camara, Seneca D Toms, Simon Williams, PhD, Sonya M Edmonds, Steven Fong, MS, PhD, Thuy T Nguyen, LCDR, Veronica Fuentes, MS, Xiaoxiao Pan, PhD, Xuhong Li, Yuan Chia Kuo, Yun Wu, PhD, Zhenzhen Liu, PhD, Zhong Li, PhD

Leslie Arivera Rosado, PhD's Documents

Publish Date Document Type Title
March, 2019 FDA 483 FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483, 2019-03-01
March, 2019 EIR FUJIFILM Diosynth Biotechnologies U.S.A., Inc - EIR, 2019-03-01
September, 2017 FDA 483 Chugai Pharmaceutical Co., Ltd. - Form 483, 2017-09-27
July, 2015 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2015-07-03
March, 2019 FDA 483 Response FUJIFILM Diosynth Biotechnologies U.S.A., Inc - Form 483R, 2019-03-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more